Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Other Operating Expenses: 2022-2024

Historic Other Operating Expenses for Silence Therapeutics (SLN) over the last 3 years, with Dec 2024 value amounting to -$113.6 million.

  • Silence Therapeutics' Other Operating Expenses rose 21.38% to -$19.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$94.4 million, marking a year-over-year change of. This contributed to the annual value of -$113.6 million for FY2024, which is 20.53% down from last year.
  • As of FY2024, Silence Therapeutics' Other Operating Expenses stood at -$113.6 million, which was down 20.53% from -$94.3 million recorded in FY2023.
  • In the past 5 years, Silence Therapeutics' Other Operating Expenses registered a high of -$80.6 million during FY2022, and its lowest value of -$113.6 million during FY2024.
  • In the last 3 years, Silence Therapeutics' Other Operating Expenses had a median value of -$94.3 million in 2023 and averaged -$96.2 million.
  • Data for Silence Therapeutics' Other Operating Expenses shows a maximum YoY fell of 20.53% (in 2024) over the last 5 years.
  • Over the past 3 years, Silence Therapeutics' Other Operating Expenses (Yearly) stood at -$80.6 million in 2022, then fell by 16.92% to -$94.3 million in 2023, then fell by 20.53% to -$113.6 million in 2024.